Brief: Mateon qtrly loss per share $0.15
08/05/2017 21:15
May 8 (Reuters) - Mateon Therapeutics Inc MATN.PK :
* Mateon provides corporate update and reports first quarter
2017 financial results
* Mateon Therapeutics Inc - qtrly loss per share $0.15
* Q1 earnings per share view $-0.13 -- Thomson Reuters
I/B/E/S
Source text for Eikon: ID:nGNXNUTBHa
Further company coverage: MATN.PK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas